Allergic diseases in childhood and adolescence

1. Immunomodulation in food allergy in its two aspects, prevention, and immunotherapy for food as a single treatment or in combination with biologics.
2. Immunomodulation in respiratory allergy: response to immunotherapy.
3. Genetics of allergic diseases: Non-IgE mediated food allergy and the international project "Establishment of a Spanish Cohort for the Genetics of Food Allergy" in collaboration with Max Delbrück Center for Molecular Medicine in Berlin
4. "Component diagnosis" in the field of food allergy and respiratory allergy
5. Treatment of skin diseases with biologics: atopic dermatitis, chronic urticaria.
6. Severe asthma with the study of inflammatory biomarkers and treatment with biologics.

1. Consolidate methods for the prevention and treatment of food allergies.
2. Study the genetic conditions of food allergy.
3. Describe phenotypes of different food allergies through advances in component diagnosis.
4. Collaborate in the international study of the action of new biological drugs in the treatment of allergic diseases in the field of food, respiratory and dermatological allergies.
5. Improve the diagnosis and treatment of severe asthma in children and adolescents.

Prevalence of allergic diseases has increased in recent decades. Lifestyle changes and improved diagnostic and laboratory-level diagnostic techniques have helped to establish a better and more accurate diagnosis. As a result, new treatments are being developed for both the immunomodulatory level and the use of biologic drugs. Many of these treatments are still in the experimental phase and our Service is a pioneer in the research that will lead to its subsequent use at a generalized level.

Food allergy mainly affects children and adolescents and is the leading cause of anaphylaxis in our environment. The aim of our research in this field is to reduce the risk of anaphylactic reactions and to improve the quality of life of children and adolescents. There are three levels of food allergy prevention: primary, secondary, and tertiary. Our lines of study are applied at all three levels with different randomized and control group studies being conducted.

In this field, the application of new techniques with component diagnosis in different foods, in agreement with the Immunology laboratory of the Clinic and other International Centers, will help to make a diagnosis.

Atopic dermatitis and chronic urticaria are also a topic of study in our group. Various randomized, double-blind, placebo-controlled international studies are being conducted to treat these conditions.

Asthma is the most common chronic disease in our environment, and allergic asthma is the most common in children. Our studies of new inflammatory biomarkers at the experimental level, in the laboratory of respiratory functional exploration, aim to improve the treatment of severe asthma.